Search Results - "Barbash, O"

Primary Uterine NUT Carcinoma: A Case Report and Literature Review.

Authors: Shiraishi, Tetsuro Kisu, Iori Kaneko, Naomi et al.

Source: Clinics & Practice. Jan2026, Vol. 16 Issue 1, p20. 8p.

CASER: A semi-supervised model with multi-omics data integration prioritizes cancer-associated epigenetic regulator genes.

Authors: Li, Hao Lin, Chaohuan Liu, Liyu et al.

Source: PLoS Computational Biology. 4/28/2026, Vol. 22 Issue 4, p1-28. 28p.

Association of a CHEK2 somatic variant with tumor microenvironment calprotectin expression predicts platinum resistance in a small cohort of ovarian carcinoma.

Authors: de Amorim, Izabela Ferreira Gontijo Melo, Carolina Pereira de Souza Pereira, Ramon de Alencar et al.

Source: PLoS ONE. 3/27/2025, Vol. 20 Issue 3, p1-16. 16p.

Comparative Evaluation of Soda and Nitrate‐Alkaline Pulping of Hemp, Flax, and Sisal Post‐harvest Biomass.

Authors: Hájková, Kateřina Bárta, Josef Filipi, Michaela et al.

Source: ChemistryOpen. Mar2026, Vol. 15 Issue 3, p1-8. 8p.

Computational assessment of the relationship between metabolism and histone methylation in cancer cells.

Authors: Koohi, Mohammad Rasouli Mehrmohamadi, Mahya

Source: PLoS ONE. 2/13/2026, Vol. 21 Issue 2, p1-21. 21p.

Mechanistic modeling of cell viability assays with in silico lineage tracing.

Authors: Mutsuddy, Arnab Huggins, Jonah R. Amrit, Aurore K. et al.

Source: PLoS Computational Biology. 8/29/2025, Vol. 21 Issue 8, p1-22. 22p.

Evaluation of Methylation and Changes in the Transcriptomics and Proteomics of the GRHL3, PHLDA3, and in Patients with Head and Neck Squamous Cell Carcinoma.

Authors: Shakoori, Abbas Azarian, Maryam Hosseinpour Aghaei, Mahdi et al.

Source: Indian Journal of Otolaryngology & Head & Neck Surgery (Springer Nature). Jan2025, Vol. 77 Issue 1, p13-21. 9p.

High-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach.

Authors: Gerges, Amgad Canning, Una

Source: Molecules. May2025, Vol. 30 Issue 10, p2211. 22p.

A SWI/SNF complex-related genes signature predicts prognosis and immune infiltration in ccRCC with KCNK5 as a novel biomarker.

Authors: Xu, Kai Yan, Zhiwei Liu, Yunxun et al.

Source: Scientific Reports. 11/21/2025, Vol. 15 Issue 1, p1-19. 19p.

Predictability: A new distinguishing feature of cancer?

Authors: Gofrit, Ofer N. Aviv, Ariel

Source: PLoS ONE. 6/12/2024, Vol. 19 Issue 6, p1-9. 9p.

Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations.

Authors: Kaneko, Syuzo Takasawa, Ken Asada, Ken et al.

Source: Molecular Cancer. 6/11/2024, Vol. 23 Issue 1, p1-17. 17p.

Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib.

Authors: Barnicle, Alan Ray-Coquard, Isabelle Rouleau, Etienne et al.

Source: Genome Medicine. 12/18/2024, Vol. 16 Issue 1, p1-16. 16p.

Precision Oncology Guided by Genomic Profiling in Breast Cancer: Real-World Data from a Molecular Tumor Board.

Authors: Graf, Tim Boos, Laura A. Mehra, Tarun et al.

Source: Cancers. Aug2025, Vol. 17 Issue 15, p2435. 18p.

Unraveling Homologous Recombination Deficiency in Ovarian Cancer: A Review of Currently Available Testing Platforms.

Authors: Marconato, Nicola Tommasi, Orazio De Paladin, Dino et al.

Source: Cancers. Jun2025, Vol. 17 Issue 11, p1771. 18p.

Prevalence of homologous recombination deficiency in ovarian, primary peritoneal, and/or fallopian tube cancer: results from HALO-Taiwan subset.

Authors: Liou, Wen-Shiung Chao, Angel Sheu, Bor-Ching et al.

Source: Journal of Gynecologic Oncology. May2026, Vol. 37 Issue 3, p1-14. 14p.

Concerns Regarding the Efficacy of Utilizing the Vibrational Response of Aminocyanine Molecules to Near Infrared Light for Cancer Cell Destruction.

Authors: Faghani-Eskandarkolaei, Parsa Welsh, James Mortazavi, Seyed Ali Reza et al.

Source: Journal of Biomedical Physics & Engineering; Apr2026, Vol. 16 Issue 2, p165-168, 4p

Pan-cancer analysis of the spectrum of homologous recombination DNA repair (HRR) pathway genes in the Indian population: A retrospective observational study.

Authors: Parween, Nasreen Gupta, Trisha Subramanyam, Paridhy et al.

Source: Cancer Research, Statistics & Treatment. Oct-Dec2023, Vol. 6 Issue 4, p512-525. 14p.

The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking.

Authors: Tsantikidi, Aikaterini Papadopoulou, Eirini Metaxa-Mariatou, Vasiliki et al.

Source: Diagnostics (2075-4418). Sep2023, Vol. 13 Issue 18, p2962. 13p.

Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.

Authors: Safaroghli-Azar A Mekonnen LB Lenjisa J et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2026 Apr 06; Vol. 19 (1). Date of Electronic Publication: 2026 Apr 06.

Publication Type: Journal Article; Review

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

A comprehensive genomic framework for identifying genes predisposing to homologous recombination repair-deficient breast or ovarian cancer.

Authors: Camacho-Valenzuela J Matis T Roca C et al.

Source: BJC reports [BJC Rep] 2026 Apr 08; Vol. 4 (1). Date of Electronic Publication: 2026 Apr 08.

Publication Type: Journal Article

Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918752188106676 Publication Model: Electronic Cited Medium: Internet ISSN: 2731-9377 (Electronic) Linking ISSN: 27319377 NLM ISO Abbreviation: BJC Rep Subsets: PubMed not MEDLINE